Drug and Medical Device Lawsuits

Diabetics warned about drug to lower blood sugar

An Irish newspaper, the Evening Herald, reports that diabetics in Europe have been warned about a drug used to lower blood sugar, which has been linked to severe side-effects.

According to the report, patients have suffered “serious hypersensitivity reactions” including anaphylactic shock and acute pancreatitis.

Both the Irish Medicines Board and the European Medicines Agency issued warnings about the drug saxagliptin, which has the brand name Onglyza, prescribed for patients with Type 2 diabetes as part of a diet and exercise program ...

continue reading...

How to find a personal injury lawyer

Should you hire a particular lawyer? Depending on your circumstances, that can be one of the most important decisions of your life. The website FindLaw provides a list of 10 suggested questions to ask a lawyer before deciding whether to proceed with him or her. While these general questions are helpful in evaluating an attorney or law firm, you should also consider the following four recommendations when evaluating a personal injury attorney:

1. If possible, find a referral from a trusted ...

continue reading...

Bloomberg: J&J sold mesh implant before FDA approval

According to a Bloomberg report, Johnson & Johnson sold a vaginal mesh implant for three years before the federal Food and Drug Administration approved the device.

The report says Johnson & Johnson introduced the Gynecare Prolift device in March 2005 without appropriate clearance. The FDA learned of the device in 2007 when Johnson & Johnson was trying to get approval for a related device.

The FDA approved both devices in 2008, after Johnson & Johnson took advantage of a loophole that obliges ...

continue reading...

Columnist: Preemptive implant removal a bad idea

A medical columnist for the British newspaper Daily Mail writes that patients should not get all-metal hip implants removed simply because they’re worried over recent reports about the devices.

Dr. Ellie Cannon acknowledged that patients who received the implants in question are likely to be alarmed about two widely reported problems. The first problem associated with these implants is that studies show the all-metal variety of artificial hip fails at a substantially earlier rate than other types, causing pain and loss ...

continue reading...

NPR broadcast examines faulty hip implants

National Public Radio’s “Morning Edition” on Monday provided an in-depth look at the problems that recipients of DePuy’s all-metal hip implants are dealing with. The company recalled the implants in 2010 because of a high early failure rate.

The broadcast actually went into the operating room at Boston’s Massachusetts General Hospital, where New Hampshire resident Susy Mansfield was undergoing surgery to remove one of the faulty devices.

The surgeon described for listeners the dead muscle and the staining on Mansfield’s tissue from ...

continue reading...

Report: Flaw in drug trials may work against women

A new study finds that women are prescribed more medications than men, but are less likely than men to use those medications as prescribed, according to a Washington Post report.

Authors of the study suggest that situation might point to an inherent flaw in the way drugs are tested in the first place. Men tend to be over-represented in early-stage drug trials, so development of medications might not take adequate account of the different way that women’s bodies absorb and metabolize ...

continue reading...
Page 134 of 139 «...110120130132133134135136...»